“If you ask patient communities their major concerns, it’s affordable access,” says Alissa Heizler-Mendoza speaking about patient advocacy in Medical Affairs.
MedInfo Teams contribute to the business with clinical expertise, extensive knowledge of the company products and medical literature, insights of customer needs, and a strong understanding of the business.
In this dynamic and conversational webinar, we will review how adaptive connected technology and processes support our mandate to deliver integrated evidence that articulates clear clinical and economic value to improve patient experience and outcomes.
The webinar will provide a snapshot of insights on what matters to patients and how pharma fares in terms of patient centricity based on a new patient centricity benchmarking survey piloted in 2019.
J&J leaders detail how to think about managing the challenge of broadening the focus of a Medical Affairs career to encompass new and multiple therapeutic areas.
This MAPS podcast identifies potential areas for compliant collaboration by medical science liaisons with key internal Medical Affairs partners
The objective of this podcast is to discuss how the 21st Century Cures Act has led to new initiatives at FDA involving Real World Evidence.
This 8th episode in our Field Medical podcast series explores the evolving roles of MSLs in the context of clinical trials.
Patient Advisors and Diversity Experts share their perspectives on diverse representation in clinical trials and key barriers to research access, and explore solutions to address these critical issues.
In this edition of Perspectives, MAPS Americas Region President, Dr John Pracyk speaks with J&J leaders about the keys to success in Medical Affairs.